Pune, Maharashtra, India
Composition
Glimepiride 2mg + Voglibose 0.2mg + Metformin Hydrochloride 500mg (SR)
DBGLIM-MV2 is a triple-combination antidiabetic tablet containing Glimepiride (sulfonylurea), Voglibose (alpha-glucosidase inhibitor), and Metformin (biguanide) in a sustained-release form for comprehensive blood sugar management.
Packing
10x15 Tablets
Storage
Cool & dry place
Form
tablet
Quality
FSSAI / GMP
Rx — Prescription Drug. This product should be used only under the supervision and prescription of a registered medical practitioner. Self-medication is not recommended.
* Not everyone experiences these side effects. Consult your doctor if symptoms persist.
Storage Instructions
Store in a cool, dry & dark place.
Packing
10x15 Tablets
Marketed By
Tawshi Healthcare Pvt. Ltd.
SR. No. 95, Mahadev Nagar, Manjari BK, Hadapsar, Pune – 412307
FSSAI License
11524079000326
Levosalbutamol + Ambroxol + Guaiphenesin
Ambroxol Hydrochloride + Levosalbutamol Sulphate + Guaiphenesin Syrup
Ambroxol Hydrochloride + Guaiphenesin + Terbutaline Sulphate + Menthol
Phenylephrine HCl + Chlorpheniramine Maleate Syrup I.P.